Browsing by Author Scott, Rob

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2016Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 StudySullivan, David; Cho, Leslie; Colquhoun, David; Dent, Ricardo; Rocco, Michael; Rosenson, Robert S; Scott, Rob; Stroes, Erik; Wasserman, Scott M; Xue, Allen; NH&MRC Clinical Trials CentreClinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study, Cardiovascular Drugs and Therapy, vol.30, 3, 2016,pp 297-304
2014Design and Rationale of the GAUSS-2 Study Trial: a Double-Blind, Ezetimibe-Controlled Phase 3 Study of the Efficacy and Tolerability of Evolocumab (AMG 145) in Subjects with Hypercholesterolemia Who Are Intolerant of Statin TherapySullivan, David; Cho, Leslie; Colquhoun, David; Dent, Ricardo; Rocco, Michael; Rosenson, Robert S; Scott, Rob; Stroes, Erik; Wasserman, Scott M; Xue, Allen; NH&MRC Clinical Trials CentreDesign and Rationale of the GAUSS-2 Study Trial: a Double-Blind, Ezetimibe-Controlled Phase 3 Study of the Efficacy and Tolerability of Evolocumab (AMG 145) in Subjects with Hypercholesterolemia Who Are Intolerant of Statin Therapy, Clinical Cardiology, vol.37, 3, 2014,pp 131-139
2015PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trialSullivan, David; Bridges, Ian; Burgess, Leslie; Cariou, B; Civeira, Fernando; Dufour, Robert; Gaudet, Daniel; Gouni-Berthold, Ioanna; Hovingh, G Kees; Langslet, Gisle; Olsson, Anders; Raal, Frederick J; Scott, Rob; Scott, Russell; Somaratne, Ransi; Stein, Evan; Turner, Traci; Wasserman, Scott M.; NH&MRC Clinical Trials CentrePCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial, The Lancet, vol.385, 9965, 2015,pp 331-340
2016Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trialKeech, Anthony (Tony); Giugliano, Robert P; Honarpour, Narimon; Liu, Thomas; Pedersen, Terje R; Sabatine, Marc S.; Scott, Rob; Sever, Peter; Wang, Huei; Wasserman, Scott M; NH&MRC Clinical Trials CentreRationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial, American Heart Journal, vol.173, N/A, 2016,pp 94-101